Peptide Documentation Governance: Buka ea ho bapala e Itokiselitsoeng ho Bafani bakeng sa Bafani, Fetola, Ho se hloeke, Lintlha le Litaolo tsa Phallo

Ha e le hantle FDA e entse eng ka li-peptide tse tšeletseng, mme ke makgaolakgang?

Peptide Pegylation Wholesale Lipatlisiso tsa Peptides Ha ho letho le qetellang. Tsebiso ea Federal Register e bulang docket e thathamisa mekhahlelo e supileng ea li-peptide bakeng sa Phupu 23-24, 2026 kopano, e 'ngoe le e' ngoe e le setsi sa mahala le acetate: BPC-157, KPV, TB-500, c-MANTSOE, Emideltide (DSIP), Semax le Epitalon (Tsebiso ea Federal Register, Docket FDA-2025-N-6895, 2026-04-16). Tsebiso e tšoanang e tlaleha 2,643 maikutlo a sechaba a kentsoeng letlapeng pele ho kopano.

Lipalo tsa likhetho lia tlalehoa, ha e hatisoe ke FDA. Bass, Berry & Sims e ngotse likhothaletso tse tšeletseng: BPC-157, KPV le TB-500 ho 8-6, Semax ho 8-5, MOTS-c ho 7-5, Epitalon ho 7-4, le Emideltide ha e khothalletsoe ho 6-7 (rekoto ea likhetho ka voutu, 2026-07-31). McDermott Will & Emery o tlaleha lipalo-palo tse tšoanang (palo ea bobeli ea lipalo, 2026). Litlaleho tse peli tsa feme ea molao tse lumellanang ke bopaki, eseng sengoloa sa FDA.

Se latelang khetho e ntle ke ho etsa melao. Karolo ea 503A e lumella lithethefatsi tse ngata hafeela li lumellana le USP/NF monograph e sebetsang., ke karolo ea moriana o amohetsoeng ke FDA, kapa e hlaha lenaneng la bongata ba 503A (ba tšoanelehang ba 503A ba itlhahloba, leqepheng la hajoale 2026-03-26). Ho kenyelletsa ntho lethathamong leo ho hloka tlhokomeliso-le-maikutlo le molao oa ho qetela, mme Frier Levitt o beha kemiso ea nako ho 12 ho 18 likhoeli kapa nako e telele ka mor'a tlhahiso (kemiso ea nako ho ea ho molao oa ho qetela, 2026-10-14). "Leano la Nakoana la Phihlello bakeng sa ho Kopanya Tšebeliso ea Li-Peptide tse itseng" le ile la ea ho OMB ho 2026-10-14; ha ea hatisoa, ha e sebetse, 'me e ka fokotsoa kapa ea tlosoa ntle le ho etsa melao (seo leano le ntseng le e-s'o hatisoe le ka se fetolang, 2026-10-16).

Ke matšoenyeho afe a boletsoeng ke FDA mabapi le lihlahisoa tse sa amoheloeng tsa GLP-1??

Khanyetso ea setsi ke lik'hemik'hale, eseng khoebo. FDA e bolela hore semaglutide sodium le semaglutide acetate ke metsoako e fapaneng e sebetsang ho tsoa ho lithethefatsi tse amohelehang, hore ha e na tlhahisoleseling eo ba e arolelanang le lik'hemik'hale tsa eona kapa tsa pharmacologic, le hore "ha ho na motheo o molaong oa tšebeliso ea bona ho kopanya" (Matšoenyeho a boletsoeng ke FDA mabapi le GLP-1 e kopaneng, 2026-01-10). Leqephe lona leo le tlaleha litlaleho tse ngata tsa liketsahalo tse mpe, ba bang ba hloka ho kena sepetlele, e hokahane le liphoso tsa dosing tse nang le ente e kopantsoeng ea semaglutide, ho kopanyelletsa le maemo ao ho 'ona litsebi tsa tlhokomelo ea bophelo li ileng tsa fosa tekanyo ea litekanyetso.

<sehlopha sa lipalo="chate ea blog" mokhoa="boholo ba bophara:640px;moeling:1.5rem auto;boholo ba fonte:12px;bophahamo ba mola:1.3;mmala:lefa"> <svg viewBox="0 0 560 380" mokhoa="boholo ba bophara: 100%; bophahamo: koloi; fonte-lelapa: 'Inter', tsamaiso-ui, sans-serif; mmala: #1e293b; --tjhate e kgutsitseng: #64748b;" karolo="img" aria-labelledby="fda-glp-1-enforcement-likes-title fda-glp-1-enforcement-actions-desc"> <setaele> /* Mofani o kenya chate ho iframe eo bokamorao ba eona bo leng botšo, mme iframe ke sebopeho se fapaneng le chate, kahoo lihlopha tsa lebokose la litlhaku li ne li bonahala e le liforeimi tse ntšo ho e potoloha (tlhahiso 09-22). Tokomane e ka hare ho iframe e pepeneneng ka ho sa feleng; ho penta mona ho akaretsa bokamorao ba lintho, 'me ha chate e kentsoe ka mola sebakeng sena sena ha se amane le letho. Boloka li-angle brackets kantle ho boloko bona: setaele se kahare ho SVG se arotsoe joalo ka litaba tsa kantle ho naha, kahoo bracket e le 'ngoe e khelohileng e lahla molao o mong le o mong o ho eona. */ html, mmele { bokamorao: #ffffff; moeling: 0; } @media (e ratang-e fokotsehile: fokotsa) { * { animation: ha ho letho !bohlokoa; phetoho: ha ho letho !bohlokoa; } } </setaele> <hantle x="0" y="0" bophara="560" bophahamo="380" rx="8" tlatsa="#ffffff" /> <title id="fda-glp-1-tiisetso-sehloho">Ts'ebetso ea ts'ebetso ea FDA GLP-1</sehlooho> <desc id="fda-glp-1-ts'ebetso-ts'ebetso-desc">FDA GLP- ts'ebetso ea ts'ebetso, joalo ka ha e reriloe ho tsoa mohloling o boletsoeng. Ts'ebetso ea ts'ebetso ea FDA GLP-1. data ea lollipop: Phuptjane 2026 leqhubu 25; Tlhakubele 2026 wave 30.Mohloli: McDermott Will & Emery; Reuters 2026-07-16.</desc> <mongolo x="280.0" y="29" mongolo-ankora="bohareng" boholo ba fonte="18" boima ba fonte="800" tlatsa="joaleMmala">Ts'ebetso ea ts'ebetso ea FDA GLP-1</mongolo> <mola x1="145" y1="298.0" x2="510" y2="298.0" stroke="joaleMmala" opacity="0.08" /> <mola x1="145" y1="243.0" x2="510" y2="243.0" stroke="joaleMmala" opacity="0.08" /> <mola x1="145" y1="188.0" x2="510" y2="188.0" stroke="joaleMmala" opacity="0.08" /> <mola x1="145" y1="133.0" x2="510" y2="133.0" stroke="joaleMmala" opacity="0.08" /> <mola x1="145" y1="78.0" x2="510" y2="78.0" stroke="joaleMmala" opacity="0.08" /> <mongolo x="136.0" y="137.0" mongolo-ankora="QETA" boholo ba fonte="11" tlatsa="joaleMmala" opacity="0.8"><tspan x="136.0" dy="0">Phuptjane 2026 leqhubu</tspan></mongolo> <mola x1="145" y1="133.0" x2="449.2" y2="133.0" stroke="joaleMmala" opacity="0.15" bophara ba stroke="1" /> <selikalikoe cx="449.2" cy="133.0" r="6" tlatsa="#f97316" /> <mongolo x="461.2" y="137.0" boholo ba fonte="11" tlatsa="joaleMmala">25</mongolo> <mongolo x="136.0" y="247.0" mongolo-ankora="QETA" boholo ba fonte="11" tlatsa="joaleMmala" opacity="0.8"><tspan x="136.0" dy="0">Tlhakubele 2026 leqhubu</tspan></mongolo> <mola x1="145" y1="243.0" x2="510.0" y2="243.0" stroke="joaleMmala" opacity="0.15" bophara ba stroke="1" /> <selikalikoe cx="510.0" cy="243.0" r="6" tlatsa="#38bdf8" /> <mongolo x="522.0" y="247.0" boholo ba fonte="11" tlatsa="joaleMmala">30</mongolo> <mongolo x="280.0" y="366" mongolo-ankora="bohareng" boholo ba fonte="10" tlatsa="tsa rona(--tjhate e kgutsitseng, joaleMmala)">Mohloli: McDermott Will & Emery; Reuters (2026-07-16)</mongolo> </svg> </setšoantšo>

Joalo ka 2026-05-31, FDA e ne e amohetse 990 litlaleho tse mpe tsa liketsahalo tsa semaglutide e kopantsoeng le ho feta 730 bakeng sa tirzepatide e kopantsoeng. FDA e hlokomela hore likhemisi tse nang le tumello ea mmuso ha lia tlameha ho tlaleha, kahoo lipalo li nyenyefatsa liketsahalo tsa sebele; li bale joalo ka fatše, eseng sekhahla.

Tlhaloso ea litokomane e tobileng. Haeba mofuta oa letsoai ke motsoako o fapaneng o sebetsang, ebe counterion ke sebaka sa lintlha, eseng mongolo o botlaaseng ba leqephe. Tlaleho e reng "semaglutide" ntle le ho reha sodium, acetate kapa setsi sa mahala se ke ke sa bapisoa le lithethefatsi tse amohelehang, ha e khone ho ts'ehetsa palo ea litaba tsa peptide, mme e ke ke ya sireletsoa. Li-pairing tsa mahala-base / acetate lenaneong la PCAC li etsa hore tšimo e be tlamo bakeng sa ntho e 'ngoe le e 'ngoe ho tse supileng tseo ho buisanoeng ka tsona..

Rekote ea ho tšoaneleha ha mofani oa thepa ea peptide e tlameha ho ba le eng?

Lenane la lipotso le tlatsitsoeng la mofani oa thepa ha se mangolo a thuto. ICH Q7 e hloka ho rekoa feela ho tsoa ho barekisi ba amohetsoeng ke Quality-Unit, kgahlanong le seo ho dumellanweng ka sona, ka tlhahlobo pele ho tumello e ka amang nalane ea boleng, lipotso, papiso ya tshekatsheko le, moo ho lokafalitsoeng, liphuputso; lisebelisoa tsa bohlokoa li fumana tlhahlobo e batsi le hore na moetsi ke mang (hore na tumello ea mofani oa Q7 e sebetsa joang, APIC v17, 2024-11).

Ho hlahloba setšeng ke sesebelisoa, eseng taelo. Palo ea APIC ea Q7 ke hore tlhahlobo ha e hlokehe mme tlhoko ea bona e lokela ho latela tlhahlobo e tlalehiloeng ea kotsi., ka makhetlo a ho hlahloba hape a behiloeng ke ts'ebetso ea mofani oa thepa le bohlokoa (hore na tumello ea mofani oa Q7 e sebetsa joang, 2024-11). Faele e nang le tlaleho ea tlhahlobo ea lichelete empa e se na tlhahlobo ea kotsi e nang le artifact ntle le mabaka.

Faele ka boeona e na le lenane la masimo. E lokela ho tlaleha tlhahlobo ea bohlokoa, leano la thuto le amohetsweng ke Boleng-Uniti, tekanyetso e loketseng bakeng sa tshebediso, lethathamo la lipotso le/kapa tlhatlhobo, litlhaloso le litumellano tsa boleng, Setifikeiti sa GMP/ISO, sephetho sa tlhahlobo se amohetsoeng ke Lekala la Boleng pele ho odara, le lenane la bafani ba amohetsoeng, ka lintlha tsa kotsi tsa mofani oa thepa tse behiloeng hang ka mor'a ho fumana mangolo (seo mofani oa thepa a lokelang ho se tšoara, APIC v2, 2024-03).

Lera la peptide le lutse ka holimo. Tataiso ea APIC mabapi le tlhahlobo e felletseng ke hore e tlameha ho akaretsa tlhahlobo e 'ngoe le e' ngoe ho latela litlhaloso tsa mosebelisi, le hore setifikeiti sa tlhahlobo ea mofani oa thepa se kanna sa se tsamaellane le litlhaloso tsa mosebelisi; tlhahlobo ea boitsebiso e lokela ho sebelisa mokhoa o khethollang, le tlhahlobo ea li-label ha ea lekana (hore na tumello ea mofani oa Q7 e sebetsa joang, 2024-11). Bakeng sa peptide e bolelang ho tsamaisa HPLC ea hau le spectrometry ea boima khahlano le litlhaloso tsa hau ho fapana le ho kenya CoA ea mofani oa thepa joalo ka rekoto ea boitsebiso..

O lokela ho fetola mosebetsi oa taolo joang bakeng sa tatellano ea peptide, mofani wa thepa kapa phetoho ya sekala?

Ho fapanyetsana ha mofani oa thepa ke phetoho ea tlhahiso ea thepa, eseng ketsahalo ya ho reka. ICH Q10 e hloka litokomane, tsamaiso ea boleng ba meriana e itšetlehileng ka kotsi ho pholletsa le bophelo bohle, ka tsamaiso ea phetoho, tsamaiso ea CAPA eo botebo ba eona ba lipatlisiso bo lekanang le kotsi tlas'a Q9, tlhahlobo ea tsamaiso, le taolo ea mesebetsi e tsoang kantle le thepa e rekiloeng, le k'hamphani e setseng e ikarabella (Tsamaiso ea phetoho ea ICH Q10 le litebello tsa CAPA, Mohato 4, 2008). Tataiso ea Q7 ea APIC e eketsa hore phetoho ea mohloli oa thepa e qalang kapa thepa ea bohlokoa e tala e lokela ho sebetsoa tlasa ts'ebetso ea taolo ea phetoho. (hore na tumello ea mofani oa Q7 e sebetsa joang, 2024-11).

Q6A e kanna ea fana ka lintlha tse tlase tsa boima ba limolek'hule tsa maiketsetso-peptide empa ha ea lekana bakeng sa litšobotsi kapa boholo ba peptide.. Q6B e akaretsa lihlahisoa tse hlalositsoeng tsa baeloji 'me ha e kenyeletse li-peptide tse entsoeng ka lik'hemik'hale. Sebelisa sehlopha sa 'nete sa sehlahisoa le tataiso e sebetsang ea peptide.

Libaka tsa rekoto tseo phetoho ea peptide e lokelang ho e jara: tatelano, N- le C-terminus, sebaka sa phetoho le k'hemistri, foromo ea counterion, ngata, ID ea mokhoa, kholomo, gradient, wavelength le standard standard. Phetoho ea counterion ho tloha Fektheri ea li-Peptides tse matlafalitsoeng trifluoroacetate ho acetate e fetola ho leka-lekana ha boima le lipalo tsa net content, kahoo e hloka data e bapisoang, eseng molaetsa. Ho fetoha ha sekhahla ho fetola ho tlosoa ha litšila, kahoo e hloka profiles tse sa hloekang sekaleng se secha.

Mokhoa oa ho hloleha o khutsitse. Tatelano e entsoeng ka tatellano ea ho kopanya ntle le mofuta oa mofuta o siea tlhaloso e supang molek'huleng eo beche e sa etsoang ho eona.. Taolo ea phetolelo ka tatellano ke rekoto ea phetoho.

Sephetho sa ho se hloeke kapa sa OOS se batlisisoa le ho koaloa joang?

Sephetho se seng se sa hlalosoang ke sesosa se hlalositsoeng, e seng pitso ya kahlolo. Tataiso ea OOS ea FDA, a May 2022 Boemo 2 tlhabollo, e akaretsa liphetho tsohle tse kantle ho maemo a boletsoeng kapa ho amoheloa ha likopo, Li-DMF, compendia kapa maemo a moetsi, hammoho le liteko tsa laboratori tse ntseng li tsoela pele ka ntle ho litlhaloso (Tataiso ea lipatlisiso tsa OOS ea FDA, leqepheng la hajoale 2024-08-01). Teko e sa sebetseng e hlolehileng e teng.

Sephetho sa ho se hloeke ha se khethehe ha feela se feta tekanyetso e sebetsang. Tlhōrō e ncha kapa e tloaelehileng e ntse e ka hloka lipatlisiso, haholo-holo haeba boitsebiso kapa kopanelo e sa rarolloa. Batlisisa ka lotho e amehileng le e ka amehang 'me u lekole maikutlo kapa ho hopola ho tloha kotsing; leha ho le joalo 0.4% kapa ho fumanoa ka mor'a ho romelloa ho etsa qeto ea hore na sephetho seo ke sefe. Fektheri ea Taelo ea Peptide

FDA e se e kentse litšila tsa peptide rekotong. Lethathamo la eona la likotsi tsa polokeho le qotsa "mathata mabapi le litšila tse amanang le peptide le motsoako o sebetsang oa meriana. (API) characterization” e le ho ameha ka BPC-157, hammoho le immunogenicity e ka khonehang bakeng sa litsela tse itseng (Lethathamo la FDA la likotsi tsa polokeho, leqepheng la hajoale 2026-04-22). Leqephe lona leo ha ho na data ea ho pepeseha ha motho e bonts'itsoeng bakeng sa KPV ka tsela efe kapa efe. Faele ea lipatlisiso tsa litšila e ke keng ea bontša ho se hloeke e araba potso eo setsi se seng se e botsitse.

Botšepehi ba data bo hloka eng boemong ba rekoto?

Litsela tsa tlhahlobo ke tšobotsi; data integrity ke sehlopha sa masimo. 21 CFR 11.10 e hloka litsamaiso tse netefalitsoeng, bokhoni ba ho etsa likopi tse nepahetseng le tse felletseng, tšireletso ea rekoto, moedi wa phihlello, Litsela tse sireletsehileng tsa tlhahlobo tse entsoeng ka nako e behiloeng ke komporo li bolokoa bonyane ha feela lirekoto, licheke tsa ts'ebetso le tsa bolaoli, le licheke tsa lisebelisoa; 11.50 e beha seo tshaeno e tlamehang ho se hlahisa, le 11.300 e laola lintlha tsa boitsebiso (Litlhokahalo tsa taolo ea Karolo ea 11, mongolo oa hajoale oa eCFR, kgutlisitsoe 2026-10-15).

Setšoantšo sa MHRA 2018 tataiso e fana ka melao-motheo ea ho hlophisa, ho kenyelletsa ALCOA + le tlhoko ea likopi tsa 'nete (Melao-motheo ea botšepehi ba data ea MHRA, Khatiso 1, 2018). Phetolelo e sebetsang ke hore rekoto e 'ngoe le e 'ngoe e tlameha ho hlahisoa, e balehang, contemporane/, ea mantlha ebile e nepahetse, mme e feletse, tsitsang, e tiisetsang ebile e fumaneha.

Rekote-kaho botjha teko

• Nomoro ea Lotho e ikemiselitse ho rekota ea batch le qeto ea tokollo

• Chromatogram e ikemiselitse ho lotho, ID ea mokhoa le kholomo

• Method e rarolla tlaleho ea eona ea netefatso le mekhoa e boletsoeng esale pele

• Tekanyetso ea litšupiso e lumellana le setifikeiti sa eona le ho felloa ke nako

• Protocol ea botsitso e rarolla sehlopha le nako

• Qeto ea tokollo e etselitsoe motho ea saenneng ka lebitso, letsatsi le moelelo

Boemo ba ho hloleha ke setifikeiti sa tlhahlobo eo chromatogram e ke keng ea bapisoa le lotho eo e reng e ea hlalosa. Seo ha se bothata ba ho fometa. Tlas'a 11.10(b) rekoto e tlameha ho fetisoa ka mokhoa o ka baloang ke motho le oa elektroniki hore o hlahlojoe, 'me chromatogram e se nang khokahano ea lotho e hloleha tlhahlobo eo pele mang kapa mang a botsa ka tsela ea tlhahlobo.

Litlhaloso tsa tokollo li aroloa joang ka bohloeki, boitsebiso, dikahare, botsitso le tekolo?

Litšobotsi tse hlano li araba lipotso tse hlano tse fapaneng, 'me ho fetola e' ngoe bakeng sa e 'ngoe ke phoso e tloaelehileng ka ho fetisisa mosebetsing oa peptide. Identity e botsa hore na molek'hule ke tatellano e reriloeng; purity e botsa hore na ke karolo efe ea sebaka sa chromatographic e leng tlhoro e kholo; litaba li botsa hore na peptide ka boima e kae e teng; botsitso bo botsa hore na ba tšoara ka nako; teko e botsa hore na ho na le ntho e sebetsang e kae khahlano le referense.

Ho netefatsa mokhoa ke hona ho etsang hore karabo e 'ngoe le e 'ngoe e sireletsehe. Ke Q2(R2) e hloka mekhoa e boletsoeng esale pele ea ts'ebetso le protocol ea netefatso e bolelang sepheo se reriloeng, tšobotsi e lekantsoeng, litšobotsi tsa tshebetso le moralo oa liteko, e nang le litšobotsi tse kenyeletsang boikhethelo/boikhethelo, mefuta-futa, nepahalo, nepahalo, phumano le meedi ya palo, le robustness (Ke Q2(R2)litšobotsi tsa netefatso, 2023-11-30, lokisitsoe 2025).

Botsitso bo na le leraba la maemo. Tataiso e kopaneng ea ICH Q1 e nkang Q1A(R2) ka Q1F le Q5C e ile ea lumelloa ho Mohato 2b ho 2025-04-11 mme e fanoe ke FDA e le tataiso ea moralo ka Phuptjane 2025, empa ha se ho kenngwa tshebetsong, kahoo Q1A(R2) (2003) e ntse e le referense ea ts'ebetso (moralo o tla nka sebaka sa Q1A(R2), 2025-06). Tlas'a moralo, setsi se secha sa lik'hemik'hale tsa maiketsetso se ntse se hloka li-batch tse tharo tsa mantlha ka 12 likhoeli nako e telele le 6 Likhoeli li potlakisitse data nakong ea tlhahiso, le 25°C/60% RH nako e telele le 40°C/75% RH maemo a potlakisang a sa fetohe (moralo o tla nka sebaka sa Q1A(R2), 2025-04-11).

Moo K/M e sebetsang ho sehlahisoa sa batsoali, sebelisa mokhoa o ikhethileng oa pyrogenic threshold le tekanyo e phahameng ka ho fetisisa nakong e boletsoeng. Boleng bo tloaelehileng ba non-intrathecal parenteral ha boa lokela ho fetisetsoa ho molomo o mong le o mong, tshebediso ya sehlooho kapa lipatlisiso. Khetha liteko tsa sterility ho latela litlhoko tsa sehlahisoa.

U hokahanya litsamaiso tse tšeletseng joang ho etsa qeto e le 'ngoe ea tokollo?

Qeto ea tokollo ke moo puso ea litokomane tsa peptide e ka tšoarellang kapa e hlolehang, hobane ke eona feela ntlha eo ho eona ho lekoa litsamaiso tsohle tse tšeletseng hang. Defensible disposition ke polelo e saennoeng e hlahang faeleng ea mofani oa thepa, tlaleho ea phetoho, histori ea lipatlisiso, mokhoa o tsitsitseng oa data, sete e netefalitsoeng e netefalitsoeng le protocol ea botsitso.

Matha heke ka tatellano 'me u emise ho hloleha ha pele:

1. Faele ea mofani e felile, ka tlhahlobo e felletseng ea mosebelisi khahlano le litlhaloso tsa mosebelisi, eseng CoA ea mofani oa thepa.

2. Rekoto ea phetoho e koetsoe, ka mofuta oa tatellano, foromo ea counterion le papiso ea sekala e ngotsoe.

3. Ha ho lipatlisiso tsa OOS tse bulehileng kapa tse sa hloekang tse amang lotho, 'me ha ho na mokhoa o sa rarolloang ho lotho e fetileng.

4. Lenane la data ha le fetohe: chromatogram ho lotho, mokhoa oa ho fana ka tlaleho ea netefatso, saena ho 11.50 ponahatso.

5. Litlhaloso li arotsoe ka boitsebiso, bohloeki, dikahare, botsitso le tekolo, e 'ngoe le e 'ngoe e na le litekanyetso tse boletsoeng esale pele.

6. Protocol ea botsitso e teng tlasa tataiso ea ts'ebetso, ka maemo a rekotiloeng ho fapana le a nahanoang.

Qeto ea tokollo e itšetlehileng ka setifikeiti sa tlhahlobo feela e hloleha mohatong 1 le mohato 4 ka nako e le nngwe. Setifikeiti ke tleleime ea morekisi; ketane ea rekoto ke bopaki ba hau.

Qetello

Setšoantšo sa taolo ho tloha ka October 2026 ha e rarolloe ke moetso. Li-peptide tse tšeletseng li na le likhothaletso tse sa tlameng, e mong ha a ka a etsa joalo, ha ho na ntho e kentsoeng lenaneng la bongata ba 503A, le pholisi ea nakoana e lutse OMB e sa phatlalatsoa (Leqephe la liboka la FDA PCAC, 2026; seo leano le ntseng le e-s'o hatisoe le ka se fetolang, 2026-10-16). Ts'ebetso ha ea ka ea emela hore ho behoe molao: barekisi ba bahlano ba amohetse mangolo ka 2026-08-24 (mangolo a mahlano a fanoeng mmoho, 2026).

Theko e fumanoeng ke molao oa liqeto. Ho lokolla lotho ea peptide ha feela mohlahlobi ea neng a le sieo ka laboratoring a ka tsamaea ho tloha nomorong ea lotho ho ea ho chromatogram ho ea ho mokhoa o eang ho tekanyetso ea litšupiso ho protocol ea botsitso ho ea boemong bo saenneng., 'me u ka bona mohatong o mong le o mong hore na rekoto e araba lipotso life. Haeba sehokelo sefe kapa sefe se hloka tlhaloso ea hau, rekoto ha e so fele.

Mohato o latelang ke tlhahlobo ea lekhalo khahlanong le matrix a mela e tšeletseng, matha ka lotho tse tharo tsa ho qetela tseo u li lokolotseng. Moo mola o senang tokomane, ke mosebetsi oo. Moo tokomane e leng teng empa e sa bolele mongolo oa eona o busang, le eona ke mosebetsi oo.

Mabapi le mohatisi. MOL Changes ke mokhatlo oa lipatlisiso le nts'etsopele oa peptide o rekisang motsoako oa peptide o tloaelehileng, lits'ebeletso tsa ntlafatso le tlhahlobo ea taolo ea boleng, kahoo e na le thahasello ea khoebo ea ho etsa peptide le litokomane. Lekanya pono ea eona ka nepo. Tataiso e ka holimo ha e itšetlehe ka lihlahisoa tsa eona.

Xiaoxia Chen

Sethethefatsi se Secha R&D Setsebi Tsebo ea Konokono: Sepheo sa ho sibolla, kamano ea sebopeho-ketso (SAR) tlhatlhobo, likhokahano tsa lithethefatsi tsa peptide (Li-PDC), le nts'etsopele ea li-peptide tse thibelang botsofali le metabolism.

Mabapi le Mongoli Litaba tsa morao-rao

Profile: Xiaoxia Chen e etelletse pele ho sibolloa ha pele le lipatlisiso tsa pele bakeng sa lithethefatsi tse 'maloa tsa peptide tse lebisitsoeng ho tumor.. Ha se setsebi feela sa tlhahlobo e phahameng ea lilaeborari tsa peptide empa hape o na le tsebo ea ho sebelisa bioloji ea khomphutha e thusitsoeng ke AI bakeng sa moralo oa tatelano ea de novo peptide.. Hajoale, o etella pele sehlopha se inehetseng ho etsa lipatlisiso tse tebileng le nts'etsopele ea li-agonists tse sebetsang tse ngata tsa moloko o latelang. (joalo ka tse peli- kapa li-peptide tse fokotsang mafura ka makhetlo a mararo) le li-peptide tsa ho lokisa lisele tse sebetsang haholo.

• Tatelano ho SMILES - Boloka Stereochemistry, Khokahano le Peptide Termini 2026年11月9日
• Tataiso ea Peptide Synthesis — Arohaneng ea ho bala ka Tatelano ea N-to-C ho Kopano 2026年11月9日
• Litšebeletso tsa Boiketsetso tsa Peptide Synthesis - Litlhokahalo tsa Sehokelo le Pholoso 2026年11月7日
• Enzymatic Peptide Synthesis — Kakaretso ea Morero bakeng sa Junction-Specific Ligation 2026年11月7日
• Tlhahiso ea lihlahisoa ho Peptide Synthesis - Beha moeli oa ho leka-lekana ha lintho 2026年11月7日

'Nete e hlahlobiloe & Litaelo tsa Bahlophisi

Mokhoa oa rona oa ho hlahloba lintlha

Re etelletsa pele ho nepahala le bots'epehi ho litaba tsa rona. Mona ke kamoo re bolokang litekanyetso tse phahameng:

1. Tlhahlobo ea Setsebi: Lingoliloeng tsohle li hlahlojoa ke litsebi tsa litaba.
2. Mohloli oa netefatso: Lintlha li tšehelitsoe ke tse tšepahalang, mehloli ea morao-rao.
3. Ponaletso: Re qotsa litšupiso ka ho hlaka le ho senola likhohlano tse ka bang teng.

E hlahlojoa ke: Litsebi tsa Litaba

Boto ea rona ea Tlhahlobo

Litaba tsa rona li hlahlojoa ka hloko ke litsebi tse nang le phihlelo ho netefatsa ho nepahala le bohlokoa.

• Litsebi Tse Tšoanelehang: Sengoliloeng se seng le se seng se hlahlojoa ke litsebi tse nang le tsebo e khethehileng ea tšimo.
• Litlhaloso tsa morao-rao: Re kenyelletsa lipatlisiso tsa morao-rao, mekhoa, le litekanyetso.
• Boitlamo ho Boleng: Bahlahlobi ba netefatsa ho hlaka, nepahalo, le botlalo.

Batla lengolo le hlahlobiloeng ke litsebi ho bala litaba tseo u ka li tšepang.